Revenue Recognition and Accounts Receivable (Tables)

6 Months Ended

Jun. 30, 2022

Revenue Recognition and Accounts Receivable

Schedule of composition of net revenues by payor type and core service lines

	Three Months Ended June 30,				Six Months Ended June 30,
	2022			2021	2022		2021
Insurance	$	436,179	$	371,869	$	857,069	$	661,879
Government		196,338		177,323		377,988		311,053
Patient pay		95,097		67,825		198,760		126,204
Net revenue	$	727,614	$	617,017	$	1,433,817	$	1,099,136

	Three Months Ended June 30,				Six Months Ended June 30,
	2022			2021	2022		2021
Net sales revenue:
Sleep	$	194,693	$	163,331	$	387,028	$	292,013
Diabetes		162,259		123,314		313,618		218,331
Supplies to the home		43,881		42,675		83,746		84,038
Respiratory		7,891		13,154		16,036		18,775
HME		31,102		30,360		61,953		54,516
Other		52,828		27,763		106,228		50,189
Total net sales revenue	$	492,654	$	400,597	$	968,609	$	717,862
Net revenue from fixed monthly equipment reimbursements:
Sleep	$	65,661	$	66,335	$	123,599	$	114,444
Diabetes		4,034		3,216		7,980		6,069
Respiratory		128,865		111,528		261,445		194,982
HME		25,547		24,431		51,272		44,811
Other		10,853		10,910		20,912		20,968
Total net revenue from fixed monthly equipment reimbursements	$	234,960	$	216,420	$	465,208	$	381,274
Total net revenue:
Sleep	$	260,354	$	229,666	$	510,627	$	406,457
Diabetes		166,293		126,530		321,598		224,400
Supplies to the home		43,881		42,675		83,746		84,038
Respiratory		136,756		124,682		277,481		213,757
HME		56,649		54,791		113,225		99,327
Other		63,681		38,673		127,140		71,157
Total net revenue	$	727,614	$	617,017	$	1,433,817	$	1,099,136